Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Researchers may have caught HIV becoming more virulent

A study from Cuba has generated wide media interest because researchers have identified a particular variety of the virus which is associated with rapid post-diagnosis falls in

Published
19 February 2015
By
Gus Cairns
The Search for a Permanent Alternative to HIV Drugs

Researchers Carefully Tailor a Study to Find Patients to Test Going Off Antiretroviral Medication

Published
16 February 2015
From
Wall Street Journal
Health News Review analysis of Reuters' coverage of new hepatitis C drugs

We wish that more stories would bring some skeptical thinking to their coverage of expensive new hepatitis C treatments. The emphasis on short-term effects obscures the lack of long-term data about benefits.

Published
13 February 2015
From
Health News Review
Next-Generation HIV and Hep C Treatment Plans Ahead at CROI

New research on the treatment and prevention of HIV/AIDS and hepatitis C will dominate the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, which this year adds a special session on Ebola.

Published
13 February 2015
From
Medscape (free registration required)
Dutrebis, New HIV Drug, Approved by FDA, but Not Commercially Available

The new combination contains 150 mg of lamivudine (3TC, Epivir) and 300 mg of raltegravir (Isentress). Despite the FDA approval, the drug manufacturer, Merck Pharmaceuticals, announced that they would not be making Dutrebis commercially available in the U.S. at this time.

Published
11 February 2015
From
The Body Pro
HIV Organizations Urge Continuation of D:A:D Study

D:A:D follows 50,000 HIV-positive people, looking at drug safety and side effects over time. Results from D:A:D have changed HIV treatment guidelines, and how HIV-positive people are treated by their health care providers. We urge pharmaceutical companies to continue funding this vital study.

Published
11 February 2015
From
Treatment Action Group
A more personalised approach to hepatitis C treatment may improve adherence and completion rates

People receiving treatment for hepatitis C value clinicians who give information and clinical feedback that is personalised to their individual needs and lifestyle, and cite this as

Published
11 February 2015
By
Roger Pebody
CROI 2015 Preview: New Research on HIV, Hepatitis C and Ebola

It's the beginning of the year, which means another Conference on Retroviruses and Opportunistic Infections (CROI) is upon us. This year's CROI takes place in Seattle and should prove to be another exciting conference as new research is presented.

Published
11 February 2015
From
The Body Pro
US: A Call for Improved HIV-Related Scientific Literacy on the Front Lines

Poor scientific literacy among non-medical members of the HIV-related workforce must be addressed in order to better fight the epidemic. Many workers are unfamiliar with biomedical prevention of HIV—using antiretrovirals to reduce the risk of HIV transmission—and don’t know enough about how and when such an intervention should be used.

Published
10 February 2015
From
AIDSMeds
More African Americans still die of HIV than whites and Latinos combined, CDC says

More African Americans still die of HIV than whites and Latinos combined, the Centers for Disease Control and Prevention reported Thursday, but the black death rate is generally declining more quickly than it is for those other groups.

Published
09 February 2015
From
Washington Post

Filter by country